代森锰锌

基本信息
制备方法及用途
物化性质
安全信息
毒理性
MSDS
海关数据
结构与计算化学

代森锰锌基本信息

中文名称：: 代森锰锌

中文别名：: 代森锰锌;
｛[1,2-亚乙基-双(二硫代氨基甲酸)](2-)｝锰锌盐;
[1,2-亚乙基-双(二硫代氨基甲酸)]锰锌盐;
乙撑双二硫代氨基甲酰锰和锌的络盐;
大生;
代森猛锌;
亚乙基双(二硫代氨基甲酸)锰锌

英文名称：: Manganese,[N-[2-[(dithiocarboxy)amino]ethyl]carbamodithioato(2-)-kS,kS']-, mixt.with [N-[2-[(dithiocarboxy)amino]ethyl]carbamodithioato(2-)-kS,kS']zinc

英文别名：: Manganese, [N-[2-[(dithiocarboxy)amino]ethyl]carbamodithioato(2-)-κS,κS']-, mixt. with [N-[2-[(dithiocarboxy)amino]ethyl]carbamodithioato(2-)-κS,κS']zinc;
Carbamic acid, ethylenebis[dithio-, manganese zinc complex (8CI);
Manganese, [[1,2-ethanediylbis[carbamodithioato]](2-)]-, mixt. with [[1,2-ethanediylbis[carbamodithioato]](2-)]zinc;
Manganese, [[2-[(dithiocarboxy)amino]ethyl]carbamodithioato(2-)-κS,κS']-, mixt. with [[2-[(dithiocarboxy)amino]ethyl]carbamodithioato(2-)-κS,κS']zinc (9CI);
Carbamodithioic acid, 1,2-ethanediylbis-, manganese complex;
Carbamodithioic acid, 1,2-ethanediylbis-, zinc complex;
Zinc, [[1,2-ethanediylbis[carbamodithioato]](2-)]-, mixt. contg.;
Zinc, [[2-[(dithiocarboxy)amino]ethyl]carbamodithioato(2-)-κS,κS']-, mixt. contg. (9CI);
Agrox 16D;
Carmazine;
Contizeb;
Daisenmengxin;
Dhanuka M 45;
Diesen M;
Dithane;
Dithane 945;
Dithane DG;
Dithane DG NT;
Dithane F;
Dithane F 45;
Dithane M 45;
Dithane M80;
Dithane Neo Tec 75WG;
Dithane OS;
Dithane Rainshield Neo Tec;
Dithane S 60;
Dithane SPC;
Dithane ultra;
F 2966;
Fore;
Green-daisen M;
Hi-shield;
Indofil 80WP;
Indofil M 45;
Jimanaisen;
Jimandaisen;
Karamate;
Karamate N;
Kascade;
Liro manzeb;
Mancomix;
Mancosan;
Mancozan;
Mancozeb;
Mancozebe Sipcam;
Mancozi;
Maneb-zinc;
Mankogal;
Manoseb;
Manzate 200;
Manzeb;
Manzidan;
Marzin;
Milcozebe;
Mycotrin;
Nemispor;
Novozir MN;
Novozir MN 80;
Othane M 45;
Pencozeb;
Penncozeb;
Pennfluid;
Sakozeb Blue;
Sancozeb;
Sandozeb Pepite;
Suncozeb;
Tanzeo M 45;
Thane M 45;
Trimanoc;
Tritogol MZ;
Vondozeb;
Ziman-Dithane;
Zimanat;
Zimaneb;
Zinc manganese ethylenebisdithiocarbamate

CAS No.：: 8018-01-7

分子式：: C₄H₆MnN₂S₄

分子量：: 265.28;275.72

精确分子量：: 538.74996

PSA：: 88.24000

MDL：: MFCD00078616

InChI：: The Key: REZOMSXFWDXCJH-UHFFFAOYSA-L

危险品标志：: Xi

风险术语：: R37;R43;

安全术语：: S8;S24/25;S46;

分子结构式：

SDS：: 查看

代森锰锌制备方法及用途

制备方法

合成制备方法

1.将代森钠与浓氯化锰液等量反应，制得浆状代森锰液。然后，将代森锰与硝酸锌或硫酸锌溶液反应，喷雾干燥得到产品。原料消耗定额：乙二胺（98%）310kg/t、二硫化碳（99%）870kg/t、氢氧化钠（30%）420kg/t、硫酸锰（98%）1020kg/t、硫酸锌（96%）80kg/t。

2.由乙二胺与二硫化碳作用，在ＮａＯＨ存在下生成代森钠，代森钠与硫酸锰作用生成代森锰，代森锰与硫酸锌作用即得代森锰锌。

用途简介

用途

1.该品为广谱的叶面保护用杀菌剂，广泛用于果树、蔬菜以及大田作物，可防治多种重要的叶部真菌病害，例如麦类锈病，玉米大斑病，马铃薯疫霉病，果树黑星病，炭疽病等。其用量为1.4-1.9kg（有效成分）/hm2。由于它用途广、药效好，已成为非内吸性的保护杀菌剂中的重要品种。与内吸性杀菌剂轮换使用或混用，可有一定的销路。
2.广谱保护性杀菌剂。广泛用于果树、蔬菜以及大田作物，可防治多种重要的叶部真菌病害。用70%可湿性粉剂500～700倍液喷雾，可防治蔬菜早疫病、灰霉、霜霉病、瓜类炭疽病。还可用于防治果树黑星病、赤星病、炭疽病等。

代森锰锌物化性质

外观与性状：
淡灰色-黄色粉末

熔点：
192-194°C

沸点：
308.2ºC at 760 mmHg

闪点：
138 °C

蒸汽压：
0.000692mmHg at 25°C

存储条件/存储方法：

其它信息：

1.      性状：灰黄色粉末
2.      密度（g/mL 25ºC）：未确定
3.      相对蒸汽密度（g/mL,空气=1）：未确定
4.      熔点（ºC常压）：未确定
5.      沸点（ºC，常压）：未确定
6.      沸点（ºC,5.2kPa）：未确定
7.      折射率（n20/D）：未确定
8.      闪点（ºC，）：137.8
9.      比旋光度（º）：未确定
10.   自燃点或引燃温度（ºC）：未确定
11.   蒸气压（kPa,25ºC）：未确定
12.   饱和蒸气压（kPa,60ºC）：未确定
13.   燃烧热（KJ/mol）：未确定
14.   临界温度（ºC）：未确定
15.   临界压力（KPa）：未确定
16.   油水（辛醇/水）分配系数的对数值（25℃）：未确定
17.   爆炸上限（%,V/V）：未确定
18.   爆炸下限（%,V/V）：未确定
19.   溶解性(mg/mL) ：未确定

代森锰锌安全信息

包装等级：
III

风险类别：
9

海关代码：
2930909055

危险类别码：
R37;R43

安全说明：
S8-S24/25-S46

RTECS号：
ZB3200000

安全标志：
S8:保持容器干燥。
S46:万一发生不慎吞咽，立刻寻求医生的建议（展示产品容器或者标签）。
S24/25:防止皮肤和眼睛接触。

危险标志：
Xi

代森锰锌毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
ZB3200000

CHEMICAL NAME :
Vondozeb

CAS REGISTRY NUMBER :
8018-01-7

LAST UPDATED :
199806

DATA ITEMS CITED :
44

MOLECULAR FORMULA :
C4-H6-Mn-N2-S4.C4-H6-N2-S4-Zn

MOLECULAR WEIGHT :
541.03
HEALTH HAZARD DATA
ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :
Oral

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
5 gm/kg

TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :
Administration onto the skin

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
>10 gm/kg

TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :
Administration onto the skin

SPECIES OBSERVED :
Rodent - rabbit

DOSE/DURATION :
>5 gm/kg

TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Oral

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
6300 mg/kg/12W-C

TOXIC EFFECTS :
Endocrine - evidence of thyroid hypofunction Endocrine - changes in thyroid weight Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Oral

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
45 gm/kg/90D-I

TOXIC EFFECTS :
Endocrine - changes in thyroid weight Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - other oxidoreductases

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Oral

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
5250 mg/kg/30D-I

TOXIC EFFECTS :
Brain and Coverings - other degenerative changes Liver - changes in liver weight Biochemical - Metabolism (Intermediary) - lipids including transport

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Oral

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
180 gm/kg/1Y-I

TOXIC EFFECTS :
Gastrointestinal - hypermotility, diarrhea Endocrine - changes in thyroid weight Related to Chronic Data - death

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Administration onto the skin

SPECIES OBSERVED :
Rodent - mouse

DOSE/DURATION :
17700 mg/kg/60W-I

TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Oral

DOSE :
1320 mg/kg

SEX/DURATION :
female 11 day(s) after conception

TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - body wall Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - eye/ear

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Oral

DOSE :
1320 mg/kg

SEX/DURATION :
female 11 day(s) after conception

TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - homeostasis

TYPE OF TEST :
TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :
Inhalation

DOSE :
500 mg/m3/6H

SEX/DURATION :
female 6-10 day(s) after conception

TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Unreported

DOSE :
2500 mg/kg

SEX/DURATION :
male 5 day(s) pre-mating

TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)

TYPE OF TEST :
Cytogenetic analysis

TYPE OF TEST :
Cytogenetic analysis

TYPE OF TEST :
Unscheduled DNA synthesis
MUTATION DATA

TEST SYSTEM :
Rodent - mouse

DOSE/DURATION :
100 mg/kg

REFERENCE :
TGANAK Tsitologiya i Genetika. Cytology and Genetics. For English translation, see CYGEDX. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1967- Volume(issue)/page/year: 16(1),45,1982 *** REVIEWS *** ACGIH TLV-TWA 0.2 mg(Mn)/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 *** U.S. STANDARDS AND REGULATIONS *** EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION FEREAC Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- Volume(issue)/page/year: 54,7740,1989 MSHA STANDARD-air:CL 5 mg(Mn)/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,149,1971 OSHA PEL (Gen Indu):CL 5 mg(Mn)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Construc):CL 5 mg(Mn)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):CL 5 mg(Mn)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 OSHA PEL (Fed Cont):CL 5 mg(Mn)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 41,50-204.50,1994 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-AUSTRALIA:TWA 5 mg(Mn)/m3 JAN 1993 OEL-BELGIUM:TWA 5 mg(Mn)/m3 JAN 1993 OEL-DENMARK:TWA 2.5 mg(Mn)/m3 JAN 1993 OEL-FINLAND:TWA 2.5 mg(Mn)/m3 JAN 1993 OEL-HUNGARY:TWA 0.3 mg(Mn)/m3;STEL 0.6 mg(Mn)/m3 JAN 1993 OEL-JAPAN:TWA 0.3 mg(Mn)/m3 JAN 1993 OEL-THE NETHERLANDS:TWA 1 mg(Mn)/m3 JAN 1993 OEL-POLAND:TWA 0.3 mg(Mn)/m3 JAN 1993 OEL-SWEDEN:TWA 1 mg(Mn)/m3;STEL 2.5 mg(Mn)/m3 (resp. dust) JAN 1993 OEL-SWEDEN:TWA 2.5 mg(Mn)/m3;STEL 5 mg(Mn)/m3 (total dust) JAN 1993 OEL-UNITED KINGDOM:TWA 5 mg(Mn)/m3 JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV

毒理学数据：

1、急性毒性：LD50：4000mg/Kg（大鼠经口）；4720mg/Kg（兔经皮）。 LC50：9400mg/m3，2小时（小鼠吸入）

代森锰锌 MSDS

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
  Product identifiers
    Product name        : Mancozeb
    : Fluka
    Index-No.        : 006-076-00-1
    CAS-No.        : 8018-01-7


Section 2. HAZARDS IDENTIFICATION
  Classification of the substance or mixture
  Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
    Reproductive toxicity (Category 2)
    Skin sensitization (Category 1)
    Acute aquatic toxicity (Category 1)
  Classification according to EU Directives 67/548/EEC or 1999/45/EC
    Very toxic to aquatic organisms. May cause sensitization by skin contact. Possible risk of harm to the
    unborn child.
  Label elements
  Labelling according Regulation (EC) No 1272/2008 [CLP]
    Pictogram
    Signal word        Warning
    Hazard statement(s)
    May cause an allergic skin reaction.
    H361d        Suspected of damaging the unborn child.
    Very toxic to aquatic life.
    Precautionary statement(s)
    Avoid release to the environment.
    Wear protective gloves.
    Supplemental Hazard        none
    Statements
  According to European Directive 67/548/EEC as amended.
    Hazard symbol(s)
    R-phrase(s)
    R43        May cause sensitization by skin contact.
    R63        Possible risk of harm to the unborn child.
    R50        Very toxic to aquatic organisms.
    S-phrase(s)
    S36/37        Wear suitable protective clothing and gloves.
    S46        If swallowed, seek medical advice immediately and show this container or
    label.
    S61        Avoid release to the environment. Refer to special instructions/ Safety
    data sheets.
  Other hazards - none

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
  Substances
    Component        Concentration
  Mancozeb
    CAS-No.        8018-01-7        -
    Index-No.        006-076-00-1

Section 4. FIRST AID MEASURES
  Description of first aid measures
  General advice
    Consult a physician. Show this safety data sheet to the doctor in attendance.
  If inhaled
    If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
  In case of skin contact
    Wash off with soap and plenty of water. Consult a physician.
  In case of eye contact
    Flush eyes with water as a precaution.
  If swallowed
    Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
  Most important symptoms and effects, both acute and delayed
  Indication of any immediate medical attention and special treatment needed
    no data available

Section 5. FIREFIGHTING MEASURES
  Extinguishing media
  Suitable extinguishing media
    Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
  Special hazards arising from the substance or mixture
    Nature of decomposition products not known.
    Nature of decomposition products not known.
    Nature of decomposition products not known.
  Advice for firefighters
    Wear self contained breathing apparatus for fire fighting if necessary.
  Further information
    no data available

Section 6. ACCIDENTAL RELEASE MEASURES
  Personal precautions, protective equipment and emergency procedures
    Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure
    adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
  Environmental precautions
    Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the
    environment must be avoided.
  Methods and materials for containment and cleaning up
    Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
    containers for disposal.
  Reference to other sections
    For disposal see section 13.

Section 7. HANDLING AND STORAGE
  Precautions for safe handling
    Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
    Provide appropriate exhaust ventilation at places where dust is formed.
  Conditions for safe storage, including any incompatibilities
    Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
    Recommended storage temperature: 2 - 8 °C
  Specific end uses
    no data available

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
  Control parameters
  Components with workplace control parameters
  Exposure controls
  Appropriate engineering controls
    Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
    at the end of workday.
  Personal protective equipment
  Eye/face protection
    Face shield and safety glasses Use equipment for eye protection tested and approved under
    appropriate government standards such as NIOSH (US) or EN 166(EU).
  Skin protection
    Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
    (without touching glove's outer surface) to avoid skin contact with this product. Dispose of
    contaminated gloves after use in accordance with applicable laws and good laboratory practices.
    Wash and dry hands.
    The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
    the standard EN 374 derived from it.
    Immersion protection
    Material: Nitrile rubber
    Minimum layer thickness: 0,11 mm
    Break through time: > 480 min
    Splash protection
    Material: Nitrile rubber
    Minimum layer thickness: 0,11 mm
    Break through time: > 30 min
    test method: EN374
    If used in solution, or mixed with other substances, and under conditions which differ from EN 374,
    contact the supplier of the CE approved gloves. This recommendation is advisory only and must
    be evaluated by an Industrial Hygienist familiar with the specific situation of anticipated use by our
    customers. It should not be construed as offering an approval for any specific use scenario.
  Body Protection
    Complete suit protecting against chemicals, The type of protective equipment must be selected
    according to the concentration and amount of the dangerous substance at the specific workplace.
  Respiratory protection
    Where risk assessment shows air-purifying respirators are appropriate use a full-face particle
    respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering
    controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use
    respirators and components tested and approved under appropriate government standards such
    as NIOSH (US) or CEN (EU).

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
  Information on basic physical and chemical properties
    a) Appearance        Form: solid
    Colour: light grey
    b) Odour        no data available
    c) Odour Threshold        no data available
    d) pH        no data available
    e) Melting point/freezing        no data available
    point
    f) Initial boiling point and no data available
    boiling range
    g) Flash point        138 °C
    h) Evaporation rate        no data available
    i) Flammability (solid, gas) no data available
    j) Upper/lower        no data available
    flammability or
    explosive limits
    k) Vapour pressure        no data available
    l) Vapour density        no data available
    m) Relative density        no data available
    n) Water solubility        insoluble
    o) Partition coefficient: n- log Pow: 1,33
    octanol/water
    p) Autoignition        no data available
    temperature
    q) Decomposition        no data available
    temperature
    r) Viscosity        no data available
    s) Explosive properties        no data available
    t) Oxidizing properties        no data available
  Other safety information
    no data available

Section 10. STABILITY AND REACTIVITY
  Reactivity
    no data available
  Chemical stability
    no data available
  Possibility of hazardous reactions
    no data available
  Conditions to avoid
    no data available
  Incompatible materials
    Strong oxidizing agents
  Hazardous decomposition products
    Other decomposition products - no data available

Section 11. TOXICOLOGICAL INFORMATION
  Information on toxicological effects
  Acute toxicity
    LD50 Oral - rat - 5.000 mg/kg
    LD50 Dermal - rabbit - > 5.000 mg/kg
  Skin corrosion/irritation
    no data available
  Serious eye damage/eye irritation
    no data available
  Respiratory or skin sensitization
    May cause allergic skin reaction.
  Germ cell mutagenicity
    Genotoxicity in vitro - Human - fibroblast
    Unscheduled DNA synthesis
    Genotoxicity in vitro - Human - lymphocyte
    Cytogenetic analysis
    Genotoxicity in vivo - rat - Oral
    Cytogenetic analysis
    Genotoxicity in vivo - mouse - Skin
    Unscheduled DNA synthesis
    Genotoxicity in vivo - mouse - Unreported
    Cytogenetic analysis
  Carcinogenicity
    Carcinogenicity - mouse - Skin
    Tumorigenic:Neoplastic by RTECS criteria. Skin and Appendages: Other: Tumors.
    IARC:        No component of this product present at levels greater than or equal to 0.1% is identified as
    probable, possible or confirmed human carcinogen by IARC.
  Reproductive toxicity
    Suspected human reproductive toxicant
    Reproductive toxicity - rat - Unreported
    Effects on Fertility: Pre-implantation mortality (e.g., reduction in number of implants per female; total
    number of implants per corpora lutea). Effects on Fertility: Post-implantation mortality (e.g., dead and/or
    resorbed implants per total number of implants).
    Developmental Toxicity - rat - Oral
    Specific Developmental Abnormalities: Central nervous system. Specific Developmental Abnormalities:
    Eye, ear.
    Developmental Toxicity - rat - Oral
    Specific Developmental Abnormalities: Craniofacial (including nose and tongue). Specific Developmental
    Abnormalities: Musculoskeletal system. Specific Developmental Abnormalities: Homeostasis
  Specific target organ toxicity - single exposure
    May cause respiratory irritation.
  Specific target organ toxicity - repeated exposure
    no data available
  Aspiration hazard
    no data available
  Potential health effects
  Inhalation        May be harmful if inhaled. Causes respiratory tract irritation.
  Ingestion        May be harmful if swallowed.
  Skin
    May be harmful if absorbed through skin. May cause skin irritation.
  Eyes        May cause eye irritation.
  Additional Information
    RTECS: ZB3200000

Section 12. ECOLOGICAL INFORMATION
  Toxicity
    Toxicity to fish        LC50 - Oncorhynchus mykiss (rainbow trout) - 1,1 mg/l - 96,0 h
    Toxicity to daphnia and EC50 - Daphnia magna (Water flea) - 0,6 - 1,0 mg/l - 48 h
    other aquatic
    invertebrates
    Toxicity to algae        EC50 - Pseudokirchneriella subcapitata (green algae) - 0,05 mg/l - 5 d
  Persistence and degradability
    no data available
  Bioaccumulative potential
    no data available
  Mobility in soil
    no data available
  Results of PBT and vPvB assessment
    no data available
  Other adverse effects
    Very toxic to aquatic life.
    Avoid release to the environment.

Section 13. DISPOSAL CONSIDERATIONS
  Waste treatment methods
  Product
    Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
    with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
  Contaminated packaging
    Dispose of as unused product.

Section 14. TRANSPORT INFORMATION
  UN number
    ADR/RID: 3077        IMDG: 3077        IATA: 3077
  UN proper shipping name
    ADR/RID: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (Mancozeb)
    IMDG: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (Mancozeb)
    IATA:        Environmentally hazardous substance, solid, n.o.s. (Mancozeb)
  Transport hazard class(es)
    ADR/RID: 9        IMDG: 9        IATA: 9
  Packaging group
    ADR/RID: III        IMDG: III        IATA: III
  Environmental hazards
    ADR/RID: yes        IMDG Marine pollutant: yes        IATA: yes
  Special precautions for user
    no data available

Section 15. REGULATORY INFORMATION
    This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
  Safety, health and environmental regulations/legislation specific for the substance or mixture
    no data available
  Chemical Safety Assessment

SECTION 16 - ADDITIONAL INFORMATION
N/A

代森锰锌海关数据

中国海关编码：2930909055

概述：

2930909055 代森锌、代森锰、代森锰锌等〔包括福美胂、福美甲胂、代森铵、代森联〕。监管条件:S(进出口农药登记证明)。增值税率:17.0%。退税率:9.0%。最低关税:6.5%。普通关税:30.0%

申报要素：

品名, 成分含量, 用途

监管条件：

S.进出口农药登记证明

摘要/Summary：

2930909055 zinc(ii) ethane-1,2-diyldicarbamodithioate。supervision conditions:s(import or export registration certificate for pesticides)。VAT:17.0%。tax rebate rate:9.0%。MFN tarrif:6.5%。general tariff:30.0%

代森锰锌分子结构与计算化学数据

分子结构数据

1、摩尔折射率：无可用的
2、摩尔体积（cm³/mol）：无可用的
3、等张比容（90.2K）：无可用的
4、表面张力（dyne/cm）：无可用的
5、介电常数：无可用的
6、极化率（10^-24cm³）：无可用的
7、单一同位素质量：330.824223 Da
8、标称质量：331 Da
9、平均质量：332.7268 Da

推荐供应商更多供应商>>

湖北诺纳科技有限公司

产品介绍：

产品名称：代森锰锌 Cas号：8018-01-7 纯度：99% 包装信息：25kg纸板桶/编织袋/塑料桶,10kg铝听/纸箱,1kg铝箔袋/氟化瓶价格：1.0元 - 25.0元

联系方式：

联系人：张经理电话：027-59209883 手机：17386169806

湖北云镁科技有限公司

产品介绍：

产品名称：代森锰锌 Cas号：8018-01-7 纯度：99% 包装信息：451kg,1kg铝箔袋/氟化瓶,10kg铝听/纸箱,25kg纸板桶/编织袋/塑料桶价格：1.0元 - 451.0元

联系方式：

联系人：方经理电话：027-59206672 手机：18327059871

湖北魏氏化学试剂股份有限公司

产品介绍：

产品名称：代森锰锌 Cas号：8018-01-7 纯度：80% 包装信息：25/纸板桶kg 价格：洽谈

联系方式：

联系人：刘涛电话：027-59101766 手机：13125137661

湖北齐飞医药化工有限公司

产品介绍：

产品名称：代森锰锌 Cas号：8018-01-7 纯度：80% 包装信息：25kg袋,10kg袋价格：洽谈

联系方式：

联系人：朱梦蝶电话：027-59322506 手机：18071128683

湖北鑫红利化工有限公司

产品介绍：

产品名称：代森锰锌 Cas号：8018-01-7 纯度：99% 包装信息：1kg铝箔袋/氟化瓶,10kg铝听/纸箱,25kg纸板桶/编织袋/塑料桶,200kg镀锌铁桶/塑料桶,1t吨袋价格：1.0元 - 1,000.0元

联系方式：

联系人：周女士电话：027-59503710 手机：18871490254

上海吉至生化科技有限公司

产品介绍：

产品名称：代森锰锌 Cas号：8018-01-7 纯度：98% 包装信息：500mgea,1gea 价格：498.0元 - 898.0元

联系方式：

联系人：江珊电话：021-57520831 手机：15316869680

苏州甫路生物科技有限公司医药推广部

产品介绍：

产品名称：代森锰锌 Cas号：8018-01-7 纯度：80% 包装信息：25/纸板桶kg 价格：1.0元

联系方式：

联系人：王经理电话：18042846216 手机：18042846216

湖北楚烁生物科技有限公司

产品介绍：

产品名称：代森锰锌 Cas号：8018-01-7 纯度：99% 包装信息：25kg 价格：100.0元

联系方式：

联系人：彭电话：19107272069 手机：19107272069

武汉本杰明医药股份有限公司

产品介绍：

产品名称：代森锰锌 Cas号：8018-01-7 纯度：包装信息：1kg,25kg 价格：洽谈

联系方式：

联系人：Maggie 张电话：027-52341919 手机：18162573931

湖北魏氏化学试剂股份有限公司

产品介绍：

产品名称：代森锰锌 Cas号：8018-01-7 纯度：80% 包装信息：25kg 价格：洽谈

联系方式：

联系人：张经理电话：027-59102966 手机：18717199209

代森锰锌

代森锰锌 基本信息

代森锰锌 制备方法及用途

制备方法

合成制备方法

用途简介

用途

代森锰锌 物化性质

代森锰锌 安全信息

代森锰锌 毒理性

CHEMICAL IDENTIFICATION

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

MUTATION DATA

代森锰锌 MSDS

代森锰锌 海关数据

中国海关编码：2930909055

代森锰锌 分子结构与计算化学数据

分子结构数据

推荐供应商更多供应商>>

湖北诺纳科技有限公司

湖北云镁科技有限公司

湖北魏氏化学试剂股份有限公司

湖北齐飞医药化工有限公司

湖北鑫红利化工有限公司

上海吉至生化科技有限公司

苏州甫路生物科技有限公司医药推广部

湖北楚烁生物科技有限公司

武汉本杰明医药股份有限公司

湖北魏氏化学试剂股份有限公司

代森锰锌基本信息

代森锰锌制备方法及用途

代森锰锌物化性质

代森锰锌安全信息

代森锰锌毒理性

代森锰锌海关数据

代森锰锌分子结构与计算化学数据